Index S&P 500
P/E 37.57
EPS (ttm) 7.08
Insider Own 6.49%
Shs Outstand 378.70M
Perf Week -2.81%
Market Cap 100.97B
Forward P/E 23.18
EPS next Y 11.47
Insider Trans -0.03%
Shs Float 355.13M
Perf Month -6.53%
Income 2.71B
PEG 3.73
EPS next Q 2.44
Inst Own 79.16%
Short Float / Ratio 1.04% / 2.87
Perf Quarter -10.59%
Sales 19.45B
P/S 5.19
EPS this Y 11.04%
Inst Trans 1.53%
Short Interest 3.69M
Perf Half Y -7.54%
Book/sh 45.71
P/B 5.82
EPS next Y 10.62%
ROA 7.38%
Target Price 320.72
Perf Year 31.27%
Cash/sh 3.89
P/C 68.32
EPS next 5Y 10.08%
ROE 16.40%
52W Range 203.23 - 306.93
Perf YTD 8.74%
Dividend 2.41
P/FCF 41.78
EPS past 5Y 18.15%
ROI 9.38%
52W High -13.38%
Beta 0.95
Dividend % 0.91%
Quick Ratio 0.84
Sales past 5Y 8.44%
Gross Margin 59.93%
52W Low 30.82%
ATR 6.44
Employees 51000
Current Ratio 1.54
Sales Q/Q 11.20%
Oper. Margin 20.54%
RSI (14) 33.33
Volatility 3.03% 2.22%
Optionable Yes
Debt/Eq 0.77
EPS Q/Q 12.00%
Profit Margin 13.92%
Rel Volume 1.56
Prev Close 273.84
Shortable Yes
LT Debt/Eq 0.66
Earnings Aug 03 AMC
Payout 45.95%
Avg Volume 1.28M
Price 265.87
Recom 1.97
SMA20 -7.15%
SMA50 -6.26%
SMA200 -4.39%
Volume 2,002,259
Change -2.91%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-05-23 Upgrade
BofA Securities
Neutral → Buy
$310 → $315
Mar-29-23 Initiated
UBS
Neutral
$287
Jan-25-23 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$240 → $284
Nov-01-22 Downgrade
Canaccord Genuity
Buy → Hold
$225 → $220
Oct-18-22 Initiated
Barclays
Overweight
$239
Oct-12-22 Initiated
Jefferies
Buy
$270
Jul-28-22 Upgrade
Edward Jones
Hold → Buy
Jul-21-22 Downgrade
Deutsche Bank
Buy → Hold
$285 → $205
Jul-11-22 Downgrade
BofA Securities
Buy → Neutral
$215
Apr-13-22 Initiated
Truist
Hold
$296
Mar-16-22 Upgrade
Bernstein
Mkt Perform → Outperform
$288 → $295
Mar-15-22 Resumed
Evercore ISI
Outperform
$284
Mar-02-22 Resumed
BofA Securities
Buy
$300
Jan-07-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$305
Jan-04-22 Upgrade
Piper Sandler
Neutral → Overweight
$250 → $315
Dec-10-21 Initiated
RBC Capital Mkts
Sector Perform
$278
Dec-07-21 Initiated
Loop Capital
Buy
$305
Sep-14-21 Resumed
Raymond James
Mkt Perform
Jul-28-21 Upgrade
Northland Capital
Market Perform → Outperform
$248 → $310
Show Previous Ratings
Oct-02-23 04:05PM
Sep-29-23 04:05PM
Sep-28-23 07:03AM
Sep-26-23 12:33PM
12:08PM
11:40AM
Loading…
Sep-25-23 11:40AM
Sep-22-23 09:49AM
Sep-21-23 07:06PM
02:07PM
Sep-19-23 09:20AM
08:30AM
08:22AM
Sep-18-23 12:39PM
Sep-15-23 12:05PM
06:45AM
08:03AM
Loading…
Sep-14-23 08:03AM
Sep-13-23 08:37AM
Sep-12-23 09:20AM
Sep-11-23 07:18PM
12:06PM
11:35AM
Sep-09-23 01:02AM
Sep-07-23 11:40AM
11:30AM
Sep-06-23 01:48AM
Sep-04-23 07:45AM
Sep-01-23 03:29PM
03:03PM
Aug-28-23 09:58AM
Aug-22-23 05:26PM
07:04AM
Loading…
Aug-09-23 07:04AM
05:30AM
Aug-08-23 01:26PM
Aug-07-23 04:05PM
Aug-04-23 04:40PM
04:00PM
03:33PM
01:58PM
09:01AM
08:02AM
07:52AM
(Thomson Reuters StreetEvents)
Aug-03-23 10:22PM
05:35PM
04:58PM
04:33PM
04:05PM
Aug-02-23 06:05PM
08:00AM
Aug-01-23 07:29AM
Jul-31-23 08:46AM
Jul-27-23 07:07PM
06:45AM
Jul-25-23 08:59AM
Jul-19-23 11:40AM
Jul-15-23 07:06AM
Jul-12-23 09:01AM
Jul-11-23 10:17AM
08:30AM
Jul-10-23 06:24AM
03:41AM
Jul-06-23 08:27AM
08:22AM
Jul-03-23 09:04AM
Jun-30-23 04:05PM
Jun-29-23 06:54PM
Jun-27-23 01:31PM
07:33AM
Jun-26-23 11:38AM
07:34AM
Jun-22-23 10:07AM
Jun-21-23 11:40AM
07:00AM
Jun-19-23 07:30AM
Jun-15-23 07:32AM
06:02AM
(Investor's Business Daily)
Jun-14-23 04:10PM
(The Wall Street Journal)
Jun-05-23 11:40AM
07:35AM
07:12AM
May-31-23 11:30AM
10:57AM
May-30-23 08:03AM
06:49AM
May-26-23 04:17PM
10:54AM
May-25-23 07:20AM
07:05AM
May-24-23 08:30AM
May-22-23 04:15PM
May-18-23 11:40AM
May-12-23 10:22AM
09:53AM
May-11-23 06:14PM
May-10-23 01:01PM
May-09-23 07:07AM
May-08-23 08:36AM
May-05-23 09:59AM
May-04-23 03:00PM
(The Wall Street Journal)
May-03-23 10:07AM
May-02-23 11:49AM
Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Menon Viju Group President Sep 06 Sale 289.00 5,000 1,445,000 6,994 Sep 08 04:20 PM Datar Srikant M. Director Aug 10 Sale 286.23 750 214,671 6,066 Aug 10 04:24 PM Datar Srikant M. Director Aug 08 Option Exercise 93.06 2,000 186,120 7,467 Aug 10 04:24 PM Datar Srikant M. Director Jun 01 Sale 278.50 500 139,250 5,467 Jun 05 05:24 PM Datar Srikant M. Director May 18 Sale 286.00 1,000 286,000 5,967 May 19 06:29 PM Caforio Giovanni Director May 04 Option Exercise 0.00 841 0 1,850 May 08 04:29 PM BRAINERD MARY K Director May 04 Option Exercise 0.00 841 0 5,110 May 08 04:22 PM Suri Rajeev Director May 04 Option Exercise 0.00 841 0 4,510 May 08 04:45 PM Skeete Tatum Lisa M Director May 04 Option Exercise 0.00 841 0 2,525 May 08 04:40 PM McCoy Sherilyn S Director May 04 Option Exercise 0.00 841 0 4,510 May 08 04:34 PM Boehnlein Glenn S VP, Chief Financial Officer Mar 21 Option Exercise 0.00 149 0 7,902 Mar 23 06:47 PM STRYKER RONDA E Director Mar 21 Option Exercise 0.00 1,048 0 2,582 Mar 23 07:16 PM Stiles Spencer S Group President Mar 21 Option Exercise 0.00 107 0 45,413 Mar 23 07:11 PM Pierce James Andrew Group President Mar 21 Option Exercise 0.00 107 0 50,610 Mar 23 07:07 PM Menon Viju Group President Mar 21 Option Exercise 0.00 88 0 13,861 Mar 23 07:03 PM Lobo Kevin Chair and CEO Mar 21 Option Exercise 0.00 504 0 99,253 Mar 23 07:00 PM Fletcher Robert S VP, Chief Legal Officer Mar 21 Option Exercise 0.00 65 0 9,030 Mar 23 06:56 PM Fink M Kathryn VP, Chief HR Officer Mar 21 Option Exercise 0.00 46 0 10,974 Mar 23 06:52 PM Becker Yin C VP, Chief Corp Affairs Officer Mar 21 Option Exercise 0.00 22 0 22,496 Mar 23 06:36 PM Golston Allan C. Director Feb 28 Option Exercise 86.69 8,150 706,527 21,687 Mar 01 05:47 PM Golston Allan C. Director Feb 28 Sale 263.27 5,459 1,437,180 13,537 Mar 01 05:47 PM Menon Viju Group President Feb 09 Sale 264.31 2,161 571,166 10,611 Feb 13 05:35 PM STRYKER RONDA E Director Feb 07 Sale 271.21 212,200 57,551,545 4,730,754 Feb 08 07:08 PM STRYKER RONDA E Director Feb 06 Sale 273.91 307,800 84,308,700 4,942,954 Feb 08 07:08 PM Fletcher Robert S VP, Chief Legal Officer Feb 03 Sale 283.54 3,000 850,610 6,636 Feb 06 06:21 PM Pierce James Andrew Group President Feb 02 Option Exercise 64.01 12,500 800,125 54,204 Feb 06 06:26 PM Berry William E Jr VP, Chief Accounting Officer Feb 02 Option Exercise 93.06 7,415 690,040 11,056 Feb 06 06:13 PM STRYKER RONDA E Director Feb 02 Option Exercise 64.01 5,520 353,335 7,054 Feb 06 06:30 PM Becker Yin C VP, Chief Corp Affairs Officer Feb 02 Option Exercise 64.01 4,885 312,689 24,096 Feb 06 06:08 PM Boehnlein Glenn S VP, Chief Financial Officer Feb 02 Sale 278.54 24,425 6,803,356 2,428 Feb 06 06:17 PM Berry William E Jr VP, Chief Accounting Officer Feb 02 Sale 279.79 4,058 1,135,370 2,886 Feb 06 06:13 PM Pierce James Andrew Group President Feb 02 Sale 277.88 400 111,152 46,676 Feb 06 06:26 PM Boehnlein Glenn S VP, Chief Financial Officer Jan 11 Option Exercise 64.01 14,515 929,105 35,286 Jan 12 07:30 PM Fink M Kathryn VP, Chief HR Officer Jan 11 Sale 257.69 6,571 1,693,309 9,264 Jan 11 07:02 PM Fink M Kathryn VP, Chief HR Officer Jan 10 Option Exercise 95.88 6,571 630,020 15,835 Jan 11 07:02 PM Fink M Kathryn VP, Chief HR Officer Jan 09 Sale 260.00 3,536 919,360 9,264 Jan 11 07:02 PM Datar Srikant M. Director Dec 07 Sale 240.25 1,000 240,255 6,262 Dec 07 04:07 PM Datar Srikant M. Director Dec 05 Option Exercise 81.14 4,355 353,365 9,216 Dec 07 04:07 PM Datar Srikant M. Director Dec 05 Sale 238.70 500 119,348 7,262 Dec 07 04:07 PM Lobo Kevin Chair and CEO Dec 02 Option Exercise 64.01 187,470 11,999,955 268,240 Dec 05 07:09 PM Lobo Kevin Chair and CEO Dec 02 Sale 239.68 67,232 16,114,299 80,770 Dec 05 07:09 PM Becker Yin C VP, Chief Corp Affairs Officer Nov 16 Option Exercise 64.01 4,885 312,689 22,139 Nov 18 04:21 PM Datar Srikant M. Director Nov 07 Sale 212.36 300 63,707 4,861 Nov 08 08:22 PM Datar Srikant M. Director Nov 02 Sale 216.71 600 130,026 5,161 Nov 04 04:18 PM Fink M Kathryn VP, Chief HR Officer Nov 02 Sale 219.68 340 74,691 12,774 Nov 03 04:49 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite